Endomag

company

About

Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
£8M
Industries
Health Care,Information Technology,Medical,Medical Device
Founded date
Jan 1, 2007
Number Of Employee
51 - 100
Operating Status
Active

Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care.

Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£25.10M
Endomag has raised a total of £25.10M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2020 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2020 Series D £15M 1 Molten Ventures Detail
Jul 23, 2018 Series C £8M 1 Molten Ventures Detail
Aug 13, 2013 Series B £2.10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Endomag is funded by 2 investors. Molten Ventures and Sarum Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Molten Ventures Yes Series D
Sarum Partners Series B